Total hip arthroplasty complications in patients with chronic kidney disease: A comparison study

It has been noted in the literature that there are increased complication rates following total hip arthroplasty (THA) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD). However, there is little data directly comparing outcomes in patients undergoing THA for osteoarthri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of orthopaedics 2023-05, Vol.39, p.1-6
Hauptverfasser: Fox, Jake A., Domingue, Grayson A., DeMaio, Christian V., Brockman, Bryan S., Malloy, Kimberly, Thakral, Rishi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue
container_start_page 1
container_title Journal of orthopaedics
container_volume 39
creator Fox, Jake A.
Domingue, Grayson A.
DeMaio, Christian V.
Brockman, Bryan S.
Malloy, Kimberly
Thakral, Rishi
description It has been noted in the literature that there are increased complication rates following total hip arthroplasty (THA) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD). However, there is little data directly comparing outcomes in patients undergoing THA for osteoarthritis (OA) versus ESRD or CKD with OA. The objective of this study is to illustrate the risk of developing postoperative complications after THA in the CKD and ESRD populations by stage of disease when compared to a control group (OA) and thus better equip orthopaedic providers in the care of these patients. The National Inpatient Sample (NIS) was utilized to identify patients undergoing elective THA from 2006 to 2015 with OA, ESRD, and CKD. The prevalence of preoperative comorbidities and the incidence of numerous postoperative complications broken into categories were examined. Between 2006 and 2015 the NIS database reported 4,350,961 patients diagnosed with OA, 8355 diagnosed with ESRD, and 104,313 diagnosed with CKD undergoing THA. The incidence of wound hematoma (2.5% vs. 0.8%; p 
doi_str_mv 10.1016/j.jor.2023.03.013
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10106339</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0972978X23000685</els_id><sourcerecordid>2803966348</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-52eac8f222f8a52470825f4234fcd1de7aa15b3df040f15be496d3c59f4f8743</originalsourceid><addsrcrecordid>eNp9UctKQzEUDKJYXx_gRrJ005rHfepCiviCgpsu3MU0ObGptzfXJFX690ZbS90IBzKQmTmHGYROKRlQQouL2WDm_IARxgckDeU76IDUJevXZfW8u4V76DCEGSGc5QXfRz1ekrKseH2AXsYuygZPbYelj1PvukaGuMTKzbvGKhmtawO2Le4ShDYG_GnjFKvEbK3Cb1a3sMTaBpABLvHwRyi9Da7FIS708hjtGdkEOFm_R2h8dzu-eeiPnu4fb4ajvuIFjf2cgVSVYYyZSuYsK0nFcpMxnhmlqYZSSppPuDYkIyYhyOpCc5XXJjNVmfEjdL2y7RaTOWiVTvWyEZ23c-mXwkkr_v60dipe3YdIQZKC8zo5nK8dvHtfQIhiboOCppEtuEUQrCK8LgqeVYlKV1TlXQgezGYPJd-GhZiJ1Iz4bkaQNJQnzdn2gRvFbxWJcLUiQErpw4IXQaXEFWjrQUWhnf3H_guzIaHu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2803966348</pqid></control><display><type>article</type><title>Total hip arthroplasty complications in patients with chronic kidney disease: A comparison study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Fox, Jake A. ; Domingue, Grayson A. ; DeMaio, Christian V. ; Brockman, Bryan S. ; Malloy, Kimberly ; Thakral, Rishi</creator><creatorcontrib>Fox, Jake A. ; Domingue, Grayson A. ; DeMaio, Christian V. ; Brockman, Bryan S. ; Malloy, Kimberly ; Thakral, Rishi</creatorcontrib><description>It has been noted in the literature that there are increased complication rates following total hip arthroplasty (THA) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD). However, there is little data directly comparing outcomes in patients undergoing THA for osteoarthritis (OA) versus ESRD or CKD with OA. The objective of this study is to illustrate the risk of developing postoperative complications after THA in the CKD and ESRD populations by stage of disease when compared to a control group (OA) and thus better equip orthopaedic providers in the care of these patients. The National Inpatient Sample (NIS) was utilized to identify patients undergoing elective THA from 2006 to 2015 with OA, ESRD, and CKD. The prevalence of preoperative comorbidities and the incidence of numerous postoperative complications broken into categories were examined. Between 2006 and 2015 the NIS database reported 4,350,961 patients diagnosed with OA, 8355 diagnosed with ESRD, and 104,313 diagnosed with CKD undergoing THA. The incidence of wound hematoma (2.5% vs. 0.8%; p &lt; .0001), wound infection (0.7% vs. 0.4%; p = .0319), cardiac (1.3% vs. 0.6%; p = .0067), urinary (3.9% vs. 2.0%; p &lt; .0001), and pulmonary complications (2.2% vs. 0.5%; p &lt; .0001) occurred more frequently in patients with OA and ESRD when compared to only OA patients. For patients with OA and CKD, stages 3–5 saw at least half of the complication categories occur at significantly higher rates than OA patients. This study shows that patients with ESRD and CKD have increased rates of complications after THA. This study's specific breakdown by stage and complication can benefit orthopaedic surgeons and practitioners in realistic pre and postoperative planning and provides data that could benefit decision making on bundled reimbursement for this specific patient population, as providers could better account for the postoperative complications noted above and their associated costs. •Patients with ESRD and CKD stages 3–5 have increased rates of complications when undergoing total hip arthroplasty.•Patients with ESRD and CKD stages 3-5 have increased rates of preoperative comorbidities when undergoing total hip arthroplasty.•Data presented in this study can benefit decision making in bundled reimbursement for this patient population.</description><identifier>ISSN: 0972-978X</identifier><identifier>EISSN: 0972-978X</identifier><identifier>DOI: 10.1016/j.jor.2023.03.013</identifier><identifier>PMID: 37077839</identifier><language>eng</language><publisher>India: Elsevier B.V</publisher><subject>Chronic kidney disease ; Hip arthroplasty ; Original article ; Osteoarthritis ; Outcomes ; Perioperative morbidity</subject><ispartof>Journal of orthopaedics, 2023-05, Vol.39, p.1-6</ispartof><rights>2023 Professor P K Surendran Memorial Education Foundation</rights><rights>2023ProfessorPKSurendranMemorialEducationFoundation.PublishedbyElsevierB.V.</rights><rights>2023ProfessorPKSurendranMemorialEducationFoundation.PublishedbyElsevierB.V. 2023 Professor P K Surendran Memorial Education Foundation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c361t-52eac8f222f8a52470825f4234fcd1de7aa15b3df040f15be496d3c59f4f8743</cites><orcidid>0000-0002-4106-7688 ; 0000-0002-4050-5447</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106339/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106339/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37077839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fox, Jake A.</creatorcontrib><creatorcontrib>Domingue, Grayson A.</creatorcontrib><creatorcontrib>DeMaio, Christian V.</creatorcontrib><creatorcontrib>Brockman, Bryan S.</creatorcontrib><creatorcontrib>Malloy, Kimberly</creatorcontrib><creatorcontrib>Thakral, Rishi</creatorcontrib><title>Total hip arthroplasty complications in patients with chronic kidney disease: A comparison study</title><title>Journal of orthopaedics</title><addtitle>J Orthop</addtitle><description>It has been noted in the literature that there are increased complication rates following total hip arthroplasty (THA) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD). However, there is little data directly comparing outcomes in patients undergoing THA for osteoarthritis (OA) versus ESRD or CKD with OA. The objective of this study is to illustrate the risk of developing postoperative complications after THA in the CKD and ESRD populations by stage of disease when compared to a control group (OA) and thus better equip orthopaedic providers in the care of these patients. The National Inpatient Sample (NIS) was utilized to identify patients undergoing elective THA from 2006 to 2015 with OA, ESRD, and CKD. The prevalence of preoperative comorbidities and the incidence of numerous postoperative complications broken into categories were examined. Between 2006 and 2015 the NIS database reported 4,350,961 patients diagnosed with OA, 8355 diagnosed with ESRD, and 104,313 diagnosed with CKD undergoing THA. The incidence of wound hematoma (2.5% vs. 0.8%; p &lt; .0001), wound infection (0.7% vs. 0.4%; p = .0319), cardiac (1.3% vs. 0.6%; p = .0067), urinary (3.9% vs. 2.0%; p &lt; .0001), and pulmonary complications (2.2% vs. 0.5%; p &lt; .0001) occurred more frequently in patients with OA and ESRD when compared to only OA patients. For patients with OA and CKD, stages 3–5 saw at least half of the complication categories occur at significantly higher rates than OA patients. This study shows that patients with ESRD and CKD have increased rates of complications after THA. This study's specific breakdown by stage and complication can benefit orthopaedic surgeons and practitioners in realistic pre and postoperative planning and provides data that could benefit decision making on bundled reimbursement for this specific patient population, as providers could better account for the postoperative complications noted above and their associated costs. •Patients with ESRD and CKD stages 3–5 have increased rates of complications when undergoing total hip arthroplasty.•Patients with ESRD and CKD stages 3-5 have increased rates of preoperative comorbidities when undergoing total hip arthroplasty.•Data presented in this study can benefit decision making in bundled reimbursement for this patient population.</description><subject>Chronic kidney disease</subject><subject>Hip arthroplasty</subject><subject>Original article</subject><subject>Osteoarthritis</subject><subject>Outcomes</subject><subject>Perioperative morbidity</subject><issn>0972-978X</issn><issn>0972-978X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9UctKQzEUDKJYXx_gRrJ005rHfepCiviCgpsu3MU0ObGptzfXJFX690ZbS90IBzKQmTmHGYROKRlQQouL2WDm_IARxgckDeU76IDUJevXZfW8u4V76DCEGSGc5QXfRz1ekrKseH2AXsYuygZPbYelj1PvukaGuMTKzbvGKhmtawO2Le4ShDYG_GnjFKvEbK3Cb1a3sMTaBpABLvHwRyi9Da7FIS708hjtGdkEOFm_R2h8dzu-eeiPnu4fb4ajvuIFjf2cgVSVYYyZSuYsK0nFcpMxnhmlqYZSSppPuDYkIyYhyOpCc5XXJjNVmfEjdL2y7RaTOWiVTvWyEZ23c-mXwkkr_v60dipe3YdIQZKC8zo5nK8dvHtfQIhiboOCppEtuEUQrCK8LgqeVYlKV1TlXQgezGYPJd-GhZiJ1Iz4bkaQNJQnzdn2gRvFbxWJcLUiQErpw4IXQaXEFWjrQUWhnf3H_guzIaHu</recordid><startdate>20230501</startdate><enddate>20230501</enddate><creator>Fox, Jake A.</creator><creator>Domingue, Grayson A.</creator><creator>DeMaio, Christian V.</creator><creator>Brockman, Bryan S.</creator><creator>Malloy, Kimberly</creator><creator>Thakral, Rishi</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4106-7688</orcidid><orcidid>https://orcid.org/0000-0002-4050-5447</orcidid></search><sort><creationdate>20230501</creationdate><title>Total hip arthroplasty complications in patients with chronic kidney disease: A comparison study</title><author>Fox, Jake A. ; Domingue, Grayson A. ; DeMaio, Christian V. ; Brockman, Bryan S. ; Malloy, Kimberly ; Thakral, Rishi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-52eac8f222f8a52470825f4234fcd1de7aa15b3df040f15be496d3c59f4f8743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chronic kidney disease</topic><topic>Hip arthroplasty</topic><topic>Original article</topic><topic>Osteoarthritis</topic><topic>Outcomes</topic><topic>Perioperative morbidity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fox, Jake A.</creatorcontrib><creatorcontrib>Domingue, Grayson A.</creatorcontrib><creatorcontrib>DeMaio, Christian V.</creatorcontrib><creatorcontrib>Brockman, Bryan S.</creatorcontrib><creatorcontrib>Malloy, Kimberly</creatorcontrib><creatorcontrib>Thakral, Rishi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of orthopaedics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fox, Jake A.</au><au>Domingue, Grayson A.</au><au>DeMaio, Christian V.</au><au>Brockman, Bryan S.</au><au>Malloy, Kimberly</au><au>Thakral, Rishi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Total hip arthroplasty complications in patients with chronic kidney disease: A comparison study</atitle><jtitle>Journal of orthopaedics</jtitle><addtitle>J Orthop</addtitle><date>2023-05-01</date><risdate>2023</risdate><volume>39</volume><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0972-978X</issn><eissn>0972-978X</eissn><abstract>It has been noted in the literature that there are increased complication rates following total hip arthroplasty (THA) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD). However, there is little data directly comparing outcomes in patients undergoing THA for osteoarthritis (OA) versus ESRD or CKD with OA. The objective of this study is to illustrate the risk of developing postoperative complications after THA in the CKD and ESRD populations by stage of disease when compared to a control group (OA) and thus better equip orthopaedic providers in the care of these patients. The National Inpatient Sample (NIS) was utilized to identify patients undergoing elective THA from 2006 to 2015 with OA, ESRD, and CKD. The prevalence of preoperative comorbidities and the incidence of numerous postoperative complications broken into categories were examined. Between 2006 and 2015 the NIS database reported 4,350,961 patients diagnosed with OA, 8355 diagnosed with ESRD, and 104,313 diagnosed with CKD undergoing THA. The incidence of wound hematoma (2.5% vs. 0.8%; p &lt; .0001), wound infection (0.7% vs. 0.4%; p = .0319), cardiac (1.3% vs. 0.6%; p = .0067), urinary (3.9% vs. 2.0%; p &lt; .0001), and pulmonary complications (2.2% vs. 0.5%; p &lt; .0001) occurred more frequently in patients with OA and ESRD when compared to only OA patients. For patients with OA and CKD, stages 3–5 saw at least half of the complication categories occur at significantly higher rates than OA patients. This study shows that patients with ESRD and CKD have increased rates of complications after THA. This study's specific breakdown by stage and complication can benefit orthopaedic surgeons and practitioners in realistic pre and postoperative planning and provides data that could benefit decision making on bundled reimbursement for this specific patient population, as providers could better account for the postoperative complications noted above and their associated costs. •Patients with ESRD and CKD stages 3–5 have increased rates of complications when undergoing total hip arthroplasty.•Patients with ESRD and CKD stages 3-5 have increased rates of preoperative comorbidities when undergoing total hip arthroplasty.•Data presented in this study can benefit decision making in bundled reimbursement for this patient population.</abstract><cop>India</cop><pub>Elsevier B.V</pub><pmid>37077839</pmid><doi>10.1016/j.jor.2023.03.013</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-4106-7688</orcidid><orcidid>https://orcid.org/0000-0002-4050-5447</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0972-978X
ispartof Journal of orthopaedics, 2023-05, Vol.39, p.1-6
issn 0972-978X
0972-978X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10106339
source EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Chronic kidney disease
Hip arthroplasty
Original article
Osteoarthritis
Outcomes
Perioperative morbidity
title Total hip arthroplasty complications in patients with chronic kidney disease: A comparison study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T10%3A25%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Total%20hip%20arthroplasty%20complications%20in%20patients%20with%20chronic%20kidney%20disease:%20A%20comparison%20study&rft.jtitle=Journal%20of%20orthopaedics&rft.au=Fox,%20Jake%20A.&rft.date=2023-05-01&rft.volume=39&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0972-978X&rft.eissn=0972-978X&rft_id=info:doi/10.1016/j.jor.2023.03.013&rft_dat=%3Cproquest_pubme%3E2803966348%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2803966348&rft_id=info:pmid/37077839&rft_els_id=S0972978X23000685&rfr_iscdi=true